Huron Consulting Group (NASDAQ:HURN) Releases FY 2024 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 5.600-6.100 for the period, compared to the consensus estimate of 5.650. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Huron Consulting Group also updated its FY24 guidance to $5.60-6.10 EPS.

Wall Street Analyst Weigh In

HURN has been the topic of several recent analyst reports. Barrington Research boosted their price target on Huron Consulting Group from $128.00 to $133.00 and gave the stock an outperform rating in a research report on Wednesday, March 6th. StockNews.com lowered Huron Consulting Group from a buy rating to a hold rating in a research report on Wednesday, February 28th.

Huron Consulting Group Stock Performance

Shares of HURN stock traded down $0.44 during trading on Tuesday, reaching $93.24. 153,217 shares of the company’s stock were exchanged, compared to its average volume of 118,551. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $1.72 billion, a PE ratio of 29.28 and a beta of 0.58. Huron Consulting Group has a twelve month low of $70.66 and a twelve month high of $113.31. The firm’s fifty day moving average price is $96.44 and its 200-day moving average price is $100.66.

Huron Consulting Group (NASDAQ:HURN) last posted its earnings results on Tuesday, February 27th. The business services provider reported $1.29 earnings per share for the quarter, topping analysts’ consensus estimates of $1.12 by $0.17. The business had revenue of $339.23 million for the quarter, compared to analyst estimates of $341.71 million. Huron Consulting Group had a return on equity of 17.77% and a net margin of 4.47%. The firm’s revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.12 EPS. As a group, sell-side analysts anticipate that Huron Consulting Group will post 5.64 EPS for the current year.

Insider Buying and Selling at Huron Consulting Group

In other news, CEO C. Mark Hussey sold 4,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $104.48, for a total transaction of $417,920.00. Following the completion of the sale, the chief executive officer now directly owns 98,286 shares in the company, valued at approximately $10,268,921.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CEO C. Mark Hussey sold 4,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $104.48, for a total transaction of $417,920.00. Following the completion of the sale, the chief executive officer now directly owns 98,286 shares in the company, valued at approximately $10,268,921.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director James H. Roth sold 2,000 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $103.22, for a total value of $206,440.00. Following the sale, the director now owns 68,040 shares of the company’s stock, valued at $7,023,088.80. The disclosure for this sale can be found here. Insiders have sold a total of 42,080 shares of company stock valued at $4,146,076 in the last ninety days. 2.20% of the stock is currently owned by corporate insiders.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.